← Back to Analyst Consensus 
HURA Buy
TuHURA Biosciences, Inc./NV
Current Price —
Implied Upside —
Analysts 10
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 13, 2026 (18 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 18, 2026 | Citizens | reiterate | Market Outperform → Market Outperform | — | 47% |
| Apr 27, 2026 | Citizens | initiate | — → Market Outperform | — | 47% |
| Feb 3, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Jan 9, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Nov 14, 2025 | Maxim Group | maintain | Buy → Buy | $8 | 42% |
| May 16, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $12 | 44% |
| Apr 3, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $12 | 44% |
| Mar 3, 2025 | HC Wainwright & Co. | initiate | — → Buy | $13 | 44% |
| Dec 19, 2024 | Rodman & Renshaw | initiate | — → Buy | $11 | 40% |
Price Target Trend
Apr 8, 2026 Oct 26, 2026
EPS Estimates
+1y —
0q —
+1q —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days